Upadacitinib in the treatment of difficult-to-treat psoriatic arthritis

被引：1
|
作者：
Graceffa, D. [1 ]
Sperati, F. [2 ]
Lora, V. [1 ]
Orsini, D. [1 ]
Spoletini, G. [3 ]
Bonifati, C. [1 ]
机构：
[1] IRCCS, San Gallicano Dermatol Inst, Dept Clin Dermatol, Via Elio Chianesi 53, I-00144 Rome, Italy
[2] IRCCS San Gallicano Dermatol Inst, UOSD Clin Trial Ctr, Biostat & Bioinformat, Rome, Italy
[3] Fdn Policlin Univ Agostino Gemelli IRCCS, Gen Surg & Liver Transplantat, Rome, Italy
来源：
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY | 2025年 / 39卷 / 02期
关键词：
D O I：
10.1111/jdv.20182
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：e138 / e140
页数：3
相关论文
共 50 条
  • [21] Abatacept in difficult-to-treat juvenile idiopathic arthritis
    Kuemmerle-Deschner, Jasmin B.
    Benseler, S. M.
    BIOLOGICS-TARGETS & THERAPY, 2008, 2 (04): : 865 - 874
  • [22] Inappropriate treatment response to DMARDs: A pathway to difficult-to-treat rheumatoid arthritis
    Guo, Hongtao
    Li, Li
    Liu, Bin
    Lu, Peipei
    Cao, Zhiwen
    Ji, Xinyu
    Ouyang, Guilin
    Nie, Zhixin
    Lyu, Aiping
    Lu, Cheng
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2023, 122
  • [23] Clinical Characteristics of Potential "Difficult-to-treat" Patients with Psoriatic Arthritis: A Retrospective Analysis of a Longitudinal Cohort
    Perrotta, Fabio Massimo
    Scriffignano, Silvia
    Ciccia, Francesco
    Lubrano, Ennio
    RHEUMATOLOGY AND THERAPY, 2022, 9 (04) : 1193 - 1201
  • [24] DIFFICULT-TO-TREAT PSORIATIC ARTHRITIS: ANALYSIS OF A SINGLE-CENTER COHORT FROM NORTHERN ITALY
    Cincinelli, G.
    Ferrito, M.
    Pandolfi, M.
    Biggioggero, M.
    Casari, S.
    Cornalba, M.
    Crotti, C.
    Desiati, F.
    Favalli, E. G.
    Manara, M.
    Caporali, R.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 1799 - 1800
  • [25] Clinical Characteristics of Potential “Difficult-to-treat” Patients with Psoriatic Arthritis: A Retrospective Analysis of a Longitudinal Cohort
    Fabio Massimo Perrotta
    Silvia Scriffignano
    Francesco Ciccia
    Ennio Lubrano
    Rheumatology and Therapy, 2022, 9 : 1193 - 1201
  • [26] Evaluating upadacitinib for the treatment of psoriatic arthritis
    Akpabio, Akpabio
    Adebajo, Adewale
    EXPERT OPINION ON PHARMACOTHERAPY, 2022, 23 (02) : 169 - 173
  • [27] Use of upadacitinib in the treatment of psoriatic arthritis
    Ross, Yael
    Magrey, Marina
    IMMUNOTHERAPY, 2021, 13 (18) : 1549 - 1554
  • [28] Diagnostic issues in difficult-to-treat rheumatoid arthritis: a systematic literature review informing the EULAR recommendations for the management of difficult-to-treat rheumatoid arthritis
    Roodenrijs, Nadia M. T.
    Kedves, Melinda
    Hamar, Attila
    Nagy, Gyorgy
    van Laar, Jacob M.
    van der Heijde, Desiree
    Welsing, Paco M. J.
    RMD OPEN, 2021, 7 (01):
  • [29] A Closer Look at the Difficult-to-Treat Rheumatoid Arthritis Patients
    Gazel, Ummugulsum
    Acikgoz, Seyyid
    Chowdhury, Rokhsana
    Ivory, Catherine
    Zahrai, Amin
    Hepworth, Elliot
    Aydin, Sibel
    JOURNAL OF RHEUMATOLOGY, 2023, 50 (07) : 43 - 44
  • [30] Difficult-to-treat psoriatic arthritis: refining the definition using a statistical model in a real-life cohort
    Favalli, Ennio Giulio
    Biganzoli, Giacomo
    Cincinelli, Gilberto
    Ferrito, Matteo
    Luconi, Ester
    Manara, Maria
    Biggioggero, Martina
    Boracchi, Patrizia
    Caporali, Roberto
    FRONTIERS IN MEDICINE, 2024, 11
12345